Table 4.

Multivariate analysis of association between either increase or decrease in blood pressure and mortality at follow‐up

	1‐month follow‐up			3‐month follow‐up			12‐month follow‐up
	HR	95% CI	p	HR	95% CI	p	HR	95% CI	p
SBP increase	1.005	0.983–1.027	.68	1.012	0.996–1.028	.145	1.005	0.989–1.021	.561
MAP increase	1.02	0.997–1.054	.242	1.022	0.991–1.053	.163	1.027	1.002–1.053	.035
SBP decrease	0.973	0.941–1.005	.098	0.981	0.957–1.006	.142	0.987	0.966–1.009	.248
MAP decrease	0.947	0.900–0.998	.041	0.946	0.909–0.984	.006	0.966	0.935–0.998	.035

HR, hazard ratio; SBP, systolic blood pressure; MAP, mean arterial pressure.

Age, sex, NIHSS score in the acute setting, congestive heart failure, diabetes mellitus (type 1 and type 2), history of ischemic stroke (IS) and SBP or MAP, respectively, were used as covariates.